当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3495291
自主品牌
已选条件
-
T67847Imatinib impurities3
Imatinib impurities3 is a protein kinases inhibitor with IC50 values of 6.95uM, 0.245uM, 0.139uM for ABL1 wt, KIT wt, PDGFRR wt, respectively.
价 格：￥电议型 号：T67847产 地：中国大陆
-
T64338AKI603AKI603,Aurora Kinase,chronic,CML,leukemia,myeloid,inhibit,imatinib-resistant,Inhibitor
AKI603 is a novel small molecule inhibitor of Aurora kinase A (AurA)(IC50 = 12.3 nM). AKI603 is developed to overcome resistance mediated by BCR-ABL-T315I mutation. AKI603 exhibits strong anti-proliferative activity in leukemic cells[1][2].
价 格：￥电议型 号：T64338产 地：中国大陆
-
T6230Imatinib伊马替尼；STI571；ST-1571；CGP057148B
matinib is an inhibitor of the receptor tyrosine kinases c-Abl, Bcr-Abl, PDGFR, and c-Kit (IC50: 600/100/100 nM).
价 格：￥电议型 号：T6230产 地：中国大陆
-
T1621Imatinib MesylateST-1571 Mesylate；CGP-57148B；STI-571；甲磺酸伊马替尼
Imatinib mesylate is a tyrosine kinase receptor inhibitor with antineoplastic activity (IC50s: 0.6 μM, 0.1 μM and 0.1 μM for v-Abl, c-Kit and PDGFR, respectively).
价 格：￥电议型 号：T1621产 地：中国大陆
-
T6230ImatinibImatinib,STI571,CGP057148B
matinib is an inhibitor of the receptor tyrosine kinases c-Abl, Bcr-Abl, PDGFR, and c-Kit (IC50: 600/100/100 nM).
价 格：￥电议型 号：T6230产 地：美洲
-
T73973Imatinib Impurity E；化合物 Imatinib Impurity EImatinib Impurity E
Imatinib Impurity E is a specific impurity found in Imatinib, an orally available inhibitor of multiple tyrosine kinases, including BCR/ABL, v-Abl, PDGFR, and c-kit. Imatinib (STI571) operates by semi-competitively inhibiting enzyme activity; it binds adjacent to the ATP binding site, inducing a closed or self-inhibited conformation [1] [2] [3] [4]. Additionally, Imatinib acts as an inhibitor against SARS-CoV and MERS-CoV [5].
价 格：￥电议型 号：T73973产 地：中国大陆
-
T67847Imatinib impurities3；伊马替尼杂质3Imatinib impurities3
Imatinib impurities3 is a protein kinases inhibitor with IC50 values of 6.95uM, 0.245uM, 0.139uM for ABL1 wt, KIT wt, PDGFRR wt, respectively.
价 格：￥电议型 号：T67847产 地：中国大陆
-
T6230Imatinib；伊马替尼STI571|||CGP057148B|||ST-1571；伊马替尼|||STI571|||CGP057148B|||ST-1571
Imatinib (STI571) is a multi-targeted receptor tyrosine kinase inhibitor that selectively inhibits the kinase activities of BCR/ABL, v-Abl, PDGFR, and c-kit with oral activity. Imatinib has antitumor activity for the treatment of chronic granulocytic leukemia.
价 格：￥电议型 号：T6230产 地：中国大陆
-
T40504N-Desmethyl imatinib mesylate；N-Desmethyl imatinib mesylateImatinibmetaboliteN-Desmethylimatinibmesy
Norimatinib mesylate, also known as N-Desmethyl imatinib mesylate, is a metabolite derived from Imatinib, which acts as a potent multi-target inhibitor of v-Abl, c-Kit, and PDGFR.
价 格：￥电议型 号：T40504产 地：中国大陆
-
T22859Imatinib hydrochloride；化合物 T22859Imatinib hydrochloride
Imatinib is a multi-target inhibitor of v-Abl, c-Kit, and PDGFR (IC50: 0.6 μM, 0.1 μM, and 0.1 μM, respectively). Imatinib is used to treat chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GISTs), and a number of other malignancies.
价 格：￥电议型 号：T22859产 地：中国大陆
-
T19451N-Desmethyl imatinib-d8；化合物 T19451Norimatinib D8|||Imatinib metabolite N-Desmethyl imatinib D8|||N-D
N-Desmethyl imatinib D8 is a deuterium labeled Imatinib metabolite N-Desmethyl Imatinib.
价 格：￥电议型 号：T19451产 地：中国大陆
-
T19015Imatinib Acid；化合物 T19015Imatinib Acid
Imatinib Acid is usually used as a fluorescent probe or labeled chemical.
价 格：￥电议型 号：T19015产 地：中国大陆
-
T18592Imatinib carbaldehyde；化合物 T18592CGP-57148B carbaldehyde|||STI571 carbaldehyde|||PROTAC ABL binding m
Imatinib carbaldehyde (also known as CGP-57148B carbaldehyde) is a compound derived from Imatinib, an inhibitor of the ABL protein. Imatinib carbaldehyde binds to the IAP ligand with the assistance of a linker, resulting in the formation of SNIPER[1].
价 格：￥电议型 号：T18592产 地：中国大陆
-
T1621Imatinib Mesylate；甲磺酸伊马替尼ST-1571 Mesylate|||STI-571|||CGP-57148B；甲磺酸伊马替尼|||ST-1571 Mesylate|||STI-57
Imatinib Mesylate (STI571 Mesylate) is a multi-targeted receptor tyrosine kinase inhibitor that selectively inhibits the kinase activities of BCR/ABL, v-Abl, PDGFR, and c-kit with oral activity. Imatinib Mesylate has antitumor activity for the treatment of chronic granulocytic leukemia.
价 格：￥电议型 号：T1621产 地：中国大陆
-
T11641N-Desmethyl imatinibN-去甲基伊马替尼Imatinib metabolite N-Desmethyl imatinib|||Norimatinib|||N-去甲基伊马替尼
N-Desmethyl imatinib (Imatinib metabolite N-Desmethyl imatinib) is a metabolite of Imatinib, which is a multi-target inhibitor of c-Kit, v-Abl, and PDGFR.
价 格：￥电议型 号：T11641产 地：中国大陆
-
T11640Imatinib-d8；化合物 T11640CGP-57148B D8|||STI571 D8；CGP-57148B D8|||STI571 D8
Imatinib D8 is a deuterium-labeled Imatinib. Imatinib is an orally bioavailable tyrosine kinases inhibitor that inhibits BCR/ABL, PDGFR, v-Abl, and c-kit kinase activity.
价 格：￥电议型 号：T11640产 地：中国大陆
